[Proceedings: Study on participation of renin-angiotensin system in various types of hypertension by clinical application of an angiotensin II analogue (1-sar, 8-Ile-angiotensin II)]. 1974

T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
March 1975, Horumon to rinsho. Clinical endocrinology,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
January 1979, Minerva nefrologica,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
November 1977, The Tohoku journal of experimental medicine,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
January 1978, Contributions to nephrology,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
January 1992, Clinical therapeutics,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
June 1974, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
July 1975, The Tohoku journal of experimental medicine,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
January 1976, Contributions to nephrology,
T Ogiwara, and K Miyai, and Y Kumabara, and T Yamamoto, and K Omori
January 1980, Nephron,
Copied contents to your clipboard!